… In the context of health emergency, drug repurposing represents the most relevant strategy …
such drugs. Herein, we aim to review drugs with in vitro antiviral activity against SARS-CoV-2, …

… For MERS-CoV transcriptome data, we queried the GEO database with the terms “MERS
CoV”, “MERS CoV AND Homo sapiens”. We screened the datasets in such a way that the …

… drug repurposing in the context of human coronaviruses, SARS-CoV, MERS-CoV, and, in
particular, SARS-CoV-2, the virus … a focus on the strategy by which the drugs were repurposed. …

… Here we summarize the present status of both virus-based and host-based drug
repurposing perspectives for coronaviruses in general and the SARS-CoV-2 in particular. …

… , and G276 of MERS-CoV PLpro. Development of drug repurposing is a remarkable opportunity
to … Protease inhibitors have been found to be effective against MERS-CoV to date, and …

… -SARS CoV and anti-HCV NS3 drugs to inhibit MERS CoV PL pro … drug repurposing is
performed to test anti-HCV and anti-SARS drugs against the Papain-like proteases of MERS CoV …

… drug repurposing screens using SARS-S and MERS-S PP entry assays to identify a set of
broad-spectrum coronavirus … as the CPE assay, but without the addition of SARS-CoV-2 virus. …

… to de novo drug discovery. In this study, we present an integrative, antiviral drug
repurposing … between the HCoV–host interactome and drug targets in the human protein–protein …

… and it is considered as a very effective strategy for drug discovery as it … novo drug discovery
process. The present review will focus on the repurposing efficacy of the currently used drugs …

… Drug repurposing is the most recent technique. The term “drug repurposing” refers to the
process of repurposing existing … Drug repurposing has long been recognized as a precise …